EDGAR Filing Documents for 0000950123-21-015897

Form DRS/A - Draft Registration Statement: [Amend]

SEC Accession No. 0000950123-21-015897

Filing Date

2021-11-26

Accepted

2021-11-24 21:22:36

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	DRS/A	2462358
2		filename2.htm	EX-10.14	328348
3		filename3.htm	EX-10.15	134145
4		filename4.htm	EX-10.16	115336
5		filename5.htm	EX-21.1	1920
6	GRAPHIC	g155225g11d11.jpg	GRAPHIC	132129
7	GRAPHIC	g155225g13a00.jpg	GRAPHIC	120926
8	GRAPHIC	g155225g22z92.jpg	GRAPHIC	112079
9	GRAPHIC	g155225g23s23.jpg	GRAPHIC	109228
10	GRAPHIC	g155225g36n42.jpg	GRAPHIC	316344
11	GRAPHIC	g155225g80r72.jpg	GRAPHIC	178075
12	GRAPHIC	g155225g83z72.jpg	GRAPHIC	155706
13	GRAPHIC	g155225g92x08.jpg	GRAPHIC	44812
14	GRAPHIC	g73339dsp42b.jpg	GRAPHIC	29956
15	GRAPHIC	g73339dsp45b.jpg	GRAPHIC	10733
16	GRAPHIC	g73339g1118021243109.jpg	GRAPHIC	3486
17	GRAPHIC	g73339g1118021243281.jpg	GRAPHIC	3710
18	GRAPHIC	g73339g21x08.jpg	GRAPHIC	18025
19	GRAPHIC	g73339g51n89.jpg	GRAPHIC	29876
20	GRAPHIC	g73339g69s26.jpg	GRAPHIC	48880
21	GRAPHIC	g73339g96q49.jpg	GRAPHIC	23696
	Complete submission text file	0000950123-21-015897.txt		4877708

Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141

Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917

Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)